Eli Lilly & Co. (LLY) option IV bid into end of year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Citi Reiterates Buy Rating on Eli Lilly (LLY)
December 20, 2024 8:43 AM ESTCiti analyst Geoff Meacham reiterated a Buy rating and $1,250.00 price target on Eli Lilly (NYSE: LLY).
The analyst comments "We expect LLY shares to be strong today on the announcement of competitor Novos (not covered) phase 3 REDEFINE-1 study of CagriSema for obesity.... More
